Leading the way to safer medication

Arsenic trioxide

Arsenic Sesquioxide Arsenic Oxidearsenous Trioxide

TRISENOX

Description

Arsenic trioxide causes morphological changes and deoxyribonucleic acid (DNA) fragmentation characteristic of apoptosis in NB4 human promyelocytic leukaemia cells in vitro. Arsenic trioxide also causes damage or degradation of the fusion protein PML/RAR alpha.

ATC Classification

Code
Title
Category
L01XX27
Arsenic trioxide
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents

Related medicines

MPI, EU: SmPC 2018: SPC: TRISENOX Concentrate for solution

2D Molecule Structure

Unique Ingredient Identifier (UNII)

S7V92P67HO - ARSENIC TRIOXIDE

CAS Registry Number

1327-53-3 - Arsenic trioxide

SNOMED-CT

72251000 - Arsenic trioxide (substance)

 
Next: Usage >